Moleculin Biotech CS (MBRX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.0600 +0.0400 (+3.92%) 04/30/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.0100 -0.0500 (-4.72%) 17:18 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select FieldsSymbol | MBRX | CRIS | BCDA | ||
Company | Moleculin Biotech CS | Curis Inc | Biocardia Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 1.0300 | 1.8200 | 3.05 | ||
High | 1.0700 | 2.1200 | 3.14 | ||
Low | 0.9374 | 1.7700 | 2.78 | ||
Last | 1.0600 | 2.1100 | 3.14 | ||
Change | +0.0400 | +0.3000 | +0.09 | ||
% Change | +3.92% | +16.57% | +2.95% | ||
Volume | 192,800 | 70,100 | 181,800 | ||
20-Day Average Volume | 321,275 | 99,460 | 76,675 | ||
Previous Close | 1.0200 | 1.8100 | 3.05 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | No | ||
Technicals | |||||
20-Day Moving Average | 0.9109 | 1.4200 | 2.10 | ||
20-Day Raw Stochastic | 88.10% | 98.91% | 95.93% | ||
20-Day Relative Strength | 50.96% | 54.33% | 67.31% | ||
Weighted Alpha | -77.92 | -80.36 | -50.75 | ||
Today's Opinion | 72% Sell | 80% Sell | 8% Buy | ||
Previous Opinion | 72% Sell | 88% Sell | 8% Buy | ||
Last Month's Opinion | 100% Sell | 100% Sell | 40% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +2.91% since 04/23/25 | +40.67% since 04/23/25 | +69.00% since 04/23/25 | ||
Low | 0.9374 on 04/30/25 | 1.4600 on 04/24/25 | 1.78 on 04/25/25 | ||
High | 1.1100 on 04/24/25 | 2.1200 on 04/30/25 | 3.20 on 04/29/25 | ||
1-Month | |||||
%Chg | +1.92% since 03/28/25 | -9.05% since 03/28/25 | +12.14% since 03/28/25 | ||
Low | 0.6900 on 04/09/25 | 1.0200 on 04/09/25 | 1.73 on 04/22/25 | ||
High | 1.1100 on 04/24/25 | 2.3600 on 03/31/25 | 3.20 on 04/29/25 | ||
3-Month | |||||
%Chg | -31.17% since 01/30/25 | -35.87% since 01/30/25 | +35.34% since 01/30/25 | ||
Low | 0.3975 on 02/12/25 | 1.0200 on 04/09/25 | 1.73 on 04/22/25 | ||
High | 3.6499 on 02/13/25 | 3.5700 on 02/03/25 | 3.20 on 04/29/25 | ||
6-Month | |||||
%Chg | -58.27% since 10/30/24 | -52.90% since 10/30/24 | +32.49% since 10/30/24 | ||
Low | 0.3975 on 02/12/25 | 1.0200 on 04/09/25 | 1.63 on 12/19/24 | ||
High | 3.6499 on 02/13/25 | 5.0000 on 11/05/24 | 3.20 on 04/29/25 | ||
Key Statistics | |||||
Market Capitalization, $K | 14,280 | 15,363 | 14,274 | ||
Shares Outstanding, K | 14,000 | 8,488 | 4,680 | ||
Annual Sales | 0 | 10,910,000 | 60,000 | ||
Annual Net Income | -21,760,000 | -43,390,000 | -7,950,000 | ||
Last Quarter Sales | 0 | 3,350,000 | 0 | ||
Last Quarter Net Income | -1,880,000 | -9,620,000 | -2,300,000 | ||
60-Month Beta | 2.19 | 3.51 | 1.21 | ||
Per-Share Information | |||||
Most Recent Earnings | -2.09 on 11/08/24 | -1.25 on 03/31/25 | -0.25 on 03/26/25 | ||
Latest Earnings Date | 05/09/25 | 05/06/25 | 05/13/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |